Metraipolis › archive › dc_4cb5ee220bc0
Dose Conversion Ratio Between Roxadustat and Daprodustat in Patients With Non-dialysis Chronic Kidney Disease — Europe PMC PMID:42732353
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42732353
- DOI
- 10.7759/cureus.114463
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T20:21:57.459Z
- SHA-256 of the archived text
b303ef989ecb0c79c7cd8cdea57b96e453a06da4b115017757c564adac6388ed- Stable URL of this page
https://metraipolis.com/documento/dc_4cb5ee220bc0
How to cite
Dose Conversion Ratio Between Roxadustat and Daprodustat in Patients With Non-dialysis Chronic Kidney Disease — Europe PMC PMID:42732353 — Europe PMC (en), https://europepmc.org/article/MED/42732353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cb5ee220bc0 (Metraipolis archive dc_4cb5ee220bc0, sha256 b303ef989ecb0c79c7cd8cdea57b96e453a06da4b115017757c564adac6388ed)
BibTeX
@misc{dc4cb5ee220bc0,
title = {Dose Conversion Ratio Between Roxadustat and Daprodustat in Patients With Non-dialysis Chronic Kidney Disease — Europe PMC PMID:42732353},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42732353},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cb5ee220bc0; sha256 b303ef989ecb0c79c7cd8cdea57b96e453a06da4b115017757c564adac6388ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42732353. Agents can read the archived copy with the MCP tool read_document.